KRAS also has multiple immunomodulatory roles, not only altering the behaviors of cancer cells, but also exerting effects on a diversity of cells in tumor microenvironment (TME), like immune cells, fibroblasts and endothelial cells (8). This evidence concerns the gene KRAS and cancer.